APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Engineering Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Genetic Engineering Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025189 pages

Choose your research edition.

Industry ResearchGenetic Engineering Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Engineering Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Genetic Engineering Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Engineering Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Engineering Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Genetic Engineering Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetic Engineering Drug include Tonghua Dongbao Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Shanghai Lansheng Guojian Pharmaceutical, Jiangsu Sihuan Bioengineering, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, Biotech Pharmaceutical, Beijing SL Pharmaceutical and 3SBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genetic Engineering Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetic Engineering Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetic Engineering Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genetic Engineering Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Genetic Engineering Drug Segment by Company

Tonghua Dongbao Pharmaceutical

Shenzhen Neptunus Interlong Bio-Technique

Shanghai Lansheng Guojian Pharmaceutical

Jiangsu Sihuan Bioengineering

Anhui Anke Biotechnology

GeneScience Pharmaceuticals

Biotech Pharmaceutical

Beijing SL Pharmaceutical

3SBio

Genetic Engineering Drug Segment by Type

Recombinant Human Insulin

Recombinant Human Growth Hormone

Recombinant Human Interferon

Recombinant Human Erythropoietin

Monoclonal Antibody

Genetic Engineering Drug Segment by Application

Medicine

Research

Agriculture

Industrial

Other

Genetic Engineering Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Engineering Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Engineering Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Engineering Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genetic Engineering Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetic Engineering Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Genetic Engineering Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Genetic Engineering Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Genetic Engineering Drug Industry Trends Table 2. Genetic Engineering Drug Industry Drivers Table 3. Genetic Engineering Drug Industry Opportunities and Challenges Table 4. Genetic Engineering Drug Industry Restraints Table 5. Global Genetic Engineering Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Genetic Engineering Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Genetic Engineering Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Genetic Engineering Drug Sales Market Share by Manufacturers Table 9. Global Genetic Engineering Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Genetic Engineering Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Genetic Engineering Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Genetic Engineering Drug Manufacturers, Product Type & Application Table 13. Global Genetic Engineering Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Genetic Engineering Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Human Insulin Table 17. Major Manufacturers of Recombinant Human Growth Hormone Table 18. Major Manufacturers of Recombinant Human Interferon Table 19. Major Manufacturers of Recombinant Human Erythropoietin Table 20. Major Manufacturers of Monoclonal Antibody Table 21. Global Genetic Engineering Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 23. Global Genetic Engineering Drug Sales by Type (2027-2032) & (k units) Table 24. Global Genetic Engineering Drug Sales Market Share by Type (2021-2026) Table 25. Global Genetic Engineering Drug Sales Market Share by Type (2027-2032) Table 26. Global Genetic Engineering Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Genetic Engineering Drug Revenue by Type (2021-2026) & (k units) Table 28. Global Genetic Engineering Drug Revenue by Type (2027-2032) & (k units) Table 29. Global Genetic Engineering Drug Revenue Market Share by Type (2021-2026) Table 30. Global Genetic Engineering Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Medicine Table 32. Major Manufacturers of Research Table 33. Major Manufacturers of Agriculture Table 34. Major Manufacturers of Industrial Table 35. Major Manufacturers of Other Table 36. Global Genetic Engineering Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 38. Global Genetic Engineering Drug Sales by Application (2027-2032) & (k units) Table 39. Global Genetic Engineering Drug Sales Market Share by Application (2021-2026) Table 40. Global Genetic Engineering Drug Sales Market Share by Application (2027-2032) Table 41. Global Genetic Engineering Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Genetic Engineering Drug Revenue by Application (2021-2026) & (k units) Table 43. Global Genetic Engineering Drug Revenue by Application (2027-2032) & (k units) Table 44. Global Genetic Engineering Drug Revenue Market Share by Application (2021-2026) Table 45. Global Genetic Engineering Drug Revenue Market Share by Application (2027-2032) Table 46. Global Genetic Engineering Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Genetic Engineering Drug Sales by Region (2021-2026) & (k units) Table 48. Global Genetic Engineering Drug Sales Market Share by Region (2021-2026) Table 49. Global Genetic Engineering Drug Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Genetic Engineering Drug Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 53. North America Genetic Engineering Drug Sales by Country (2027-2032) & (k units) Table 54. Europe Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 56. Europe Genetic Engineering Drug Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Genetic Engineering Drug Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Genetic Engineering Drug Sales by Country (2027-2032) & (k units) Table 63. Global Genetic Engineering Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Genetic Engineering Drug Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Genetic Engineering Drug Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Genetic Engineering Drug Revenue Market Share by Region (2021-2026) Table 67. Global Genetic Engineering Drug Revenue Market Share by Region (2027-2032) Table 68. Tonghua Dongbao Pharmaceutical Company Information Table 69. Tonghua Dongbao Pharmaceutical Business Overview Table 70. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio Table 72. Tonghua Dongbao Pharmaceutical Recent Development Table 73. Shenzhen Neptunus Interlong Bio-Technique Company Information Table 74. Shenzhen Neptunus Interlong Bio-Technique Business Overview Table 75. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio Table 77. Shenzhen Neptunus Interlong Bio-Technique Recent Development Table 78. Shanghai Lansheng Guojian Pharmaceutical Company Information Table 79. Shanghai Lansheng Guojian Pharmaceutical Business Overview Table 80. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio Table 82. Shanghai Lansheng Guojian Pharmaceutical Recent Development Table 83. Jiangsu Sihuan Bioengineering Company Information Table 84. Jiangsu Sihuan Bioengineering Business Overview Table 85. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio Table 87. Jiangsu Sihuan Bioengineering Recent Development Table 88. Anhui Anke Biotechnology Company Information Table 89. Anhui Anke Biotechnology Business Overview Table 90. Anhui Anke Biotechnology Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio Table 92. Anhui Anke Biotechnology Recent Development Table 93. GeneScience Pharmaceuticals Company Information Table 94. GeneScience Pharmaceuticals Business Overview Table 95. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio Table 97. GeneScience Pharmaceuticals Recent Development Table 98. Biotech Pharmaceutical Company Information Table 99. Biotech Pharmaceutical Business Overview Table 100. Biotech Pharmaceutical Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio Table 102. Biotech Pharmaceutical Recent Development Table 103. Beijing SL Pharmaceutical Company Information Table 104. Beijing SL Pharmaceutical Business Overview Table 105. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio Table 107. Beijing SL Pharmaceutical Recent Development Table 108. 3SBio Company Information Table 109. 3SBio Business Overview Table 110. 3SBio Genetic Engineering Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. 3SBio Genetic Engineering Drug Product Portfolio Table 112. 3SBio Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Genetic Engineering Drug Distributors List Table 116. Genetic Engineering Drug Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Genetic Engineering Drug Product Image Figure 2. Global Genetic Engineering Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetic Engineering Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetic Engineering Drug Sales (2021-2032) & (k units) Figure 5. Global Genetic Engineering Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Genetic Engineering Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Human Insulin Image Figure 9. Recombinant Human Growth Hormone Image Figure 10. Recombinant Human Interferon Image Figure 11. Recombinant Human Erythropoietin Image Figure 12. Monoclonal Antibody Image Figure 13. Global Genetic Engineering Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Genetic Engineering Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Genetic Engineering Drug Sales Market Share by Type (2021-2032) Figure 16. Global Genetic Engineering Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Genetic Engineering Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Genetic Engineering Drug Revenue Market Share by Type (2021-2032) Figure 19. Medicine Image Figure 20. Research Image Figure 21. Agriculture Image Figure 22. Industrial Image Figure 23. Other Image Figure 24. Global Genetic Engineering Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Genetic Engineering Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Genetic Engineering Drug Sales Market Share by Application (2021-2032) Figure 27. Global Genetic Engineering Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Genetic Engineering Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Genetic Engineering Drug Revenue Market Share by Application (2021-2032) Figure 30. North America Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Genetic Engineering Drug Sales Market Share by Country (2021-2032) Figure 32. U.S. Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Genetic Engineering Drug Sales Market Share by Country (2021-2032) Figure 37. Germany Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Genetic Engineering Drug Sales Market Share by Country (2021-2032) Figure 44. China Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Genetic Engineering Drug Sales Market Share by Country (2021-2032) Figure 52. Brazil Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Genetic Engineering Drug Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Genetic Engineering Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Genetic Engineering Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Genetic Engineering Drug Revenue (2021-2032) & (US$ Million) Figure 63. North America Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Genetic Engineering Drug Revenue (2021-2032) & (US$ Million) Figure 65. Europe Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Genetic Engineering Drug Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Genetic Engineering Drug Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Genetic Engineering Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Genetic Engineering Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Human Insulin
  • Recombinant Human Growth Hormone
  • Recombinant Human Interferon
  • Recombinant Human Erythropoietin
  • Monoclonal Antibody
Applications
  • Medicine
  • Research
  • Agriculture
  • Industrial
  • Other
Companies covered
  • Tonghua Dongbao Pharmaceutical
  • Shenzhen Neptunus Interlong Bio-Technique
  • Shanghai Lansheng Guojian Pharmaceutical
  • Jiangsu Sihuan Bioengineering
  • Anhui Anke Biotechnology
  • GeneScience Pharmaceuticals
  • Biotech Pharmaceutical
  • Beijing SL Pharmaceutical
  • 3SBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genetic Engineering Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genetic Engineering Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Genetic Engineering Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Genetic Engineering Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Genetic Engineering Drug Market Dynamics
  1. 2.1 Genetic Engineering Drug Industry Trends
  2. 2.2 Genetic Engineering Drug Industry Drivers
  3. 2.3 Genetic Engineering Drug Industry Opportunities and Challenges
  4. 2.4 Genetic Engineering Drug Industry Restraints
3 Genetic Engineering Drug Market by Manufacturers
  1. 3.1 Global Genetic Engineering Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Genetic Engineering Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Genetic Engineering Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Genetic Engineering Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genetic Engineering Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Genetic Engineering Drug Manufacturers, Product Type & Application
  7. 3.7 Global Genetic Engineering Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genetic Engineering Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genetic Engineering Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genetic Engineering Drug Tier 1, Tier 2, and Tier 3
4 Genetic Engineering Drug Market by Type
  1. 4.1 Genetic Engineering Drug Type Introduction
  2. 4.1.1 Recombinant Human Insulin
  3. 4.1.2 Recombinant Human Growth Hormone
  4. 4.1.3 Recombinant Human Interferon
  5. 4.1.4 Recombinant Human Erythropoietin
  6. 4.1.5 Monoclonal Antibody
  7. 4.2 Global Genetic Engineering Drug Sales by Type
  8. 4.2.1 Global Genetic Engineering Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Genetic Engineering Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Genetic Engineering Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Genetic Engineering Drug Revenue by Type
  12. 4.3.1 Global Genetic Engineering Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Genetic Engineering Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Genetic Engineering Drug Revenue Market Share by Type (2021-2032)
5 Genetic Engineering Drug Market by Application
  1. 5.1 Genetic Engineering Drug Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Research
  4. 5.1.3 Agriculture
  5. 5.1.4 Industrial
  6. 5.1.5 Other
  7. 5.2 Global Genetic Engineering Drug Sales by Application
  8. 5.2.1 Global Genetic Engineering Drug Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Genetic Engineering Drug Sales by Application (2021-2032)
  10. 5.2.3 Global Genetic Engineering Drug Sales Market Share by Application (2021-2032)
  11. 5.3 Global Genetic Engineering Drug Revenue by Application
  12. 5.3.1 Global Genetic Engineering Drug Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Genetic Engineering Drug Revenue by Application (2021-2032)
  14. 5.3.3 Global Genetic Engineering Drug Revenue Market Share by Application (2021-2032)
6 Global Genetic Engineering Drug Sales by Region
  1. 6.1 Global Genetic Engineering Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genetic Engineering Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Genetic Engineering Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Genetic Engineering Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Genetic Engineering Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Genetic Engineering Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Genetic Engineering Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Genetic Engineering Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Genetic Engineering Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Genetic Engineering Drug Revenue by Region
  1. 7.1 Global Genetic Engineering Drug Revenue by Region
  2. 7.1.1 Global Genetic Engineering Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Genetic Engineering Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Genetic Engineering Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Genetic Engineering Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Genetic Engineering Drug Revenue (2021-2032)
  8. 7.2.2 North America Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Genetic Engineering Drug Revenue (2021-2032)
  11. 7.3.2 Europe Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Genetic Engineering Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Genetic Engineering Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Genetic Engineering Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tonghua Dongbao Pharmaceutical
  2. 8.1.1 Tonghua Dongbao Pharmaceutical Company Information
  3. 8.1.2 Tonghua Dongbao Pharmaceutical Business Overview
  4. 8.1.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio
  6. 8.1.5 Tonghua Dongbao Pharmaceutical Recent Developments
  7. 8.2 Shenzhen Neptunus Interlong Bio-Technique
  8. 8.2.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
  9. 8.2.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
  10. 8.2.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio
  12. 8.2.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
  13. 8.3 Shanghai Lansheng Guojian Pharmaceutical
  14. 8.3.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
  15. 8.3.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio
  18. 8.3.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Sihuan Bioengineering
  20. 8.4.1 Jiangsu Sihuan Bioengineering Company Information
  21. 8.4.2 Jiangsu Sihuan Bioengineering Business Overview
  22. 8.4.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio
  24. 8.4.5 Jiangsu Sihuan Bioengineering Recent Developments
  25. 8.5 Anhui Anke Biotechnology
  26. 8.5.1 Anhui Anke Biotechnology Company Information
  27. 8.5.2 Anhui Anke Biotechnology Business Overview
  28. 8.5.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio
  30. 8.5.5 Anhui Anke Biotechnology Recent Developments
  31. 8.6 GeneScience Pharmaceuticals
  32. 8.6.1 GeneScience Pharmaceuticals Company Information
  33. 8.6.2 GeneScience Pharmaceuticals Business Overview
  34. 8.6.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio
  36. 8.6.5 GeneScience Pharmaceuticals Recent Developments
  37. 8.7 Biotech Pharmaceutical
  38. 8.7.1 Biotech Pharmaceutical Company Information
  39. 8.7.2 Biotech Pharmaceutical Business Overview
  40. 8.7.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio
  42. 8.7.5 Biotech Pharmaceutical Recent Developments
  43. 8.8 Beijing SL Pharmaceutical
  44. 8.8.1 Beijing SL Pharmaceutical Company Information
  45. 8.8.2 Beijing SL Pharmaceutical Business Overview
  46. 8.8.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio
  48. 8.8.5 Beijing SL Pharmaceutical Recent Developments
  49. 8.9 3SBio
  50. 8.9.1 3SBio Company Information
  51. 8.9.2 3SBio Business Overview
  52. 8.9.3 3SBio Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 3SBio Genetic Engineering Drug Product Portfolio
  54. 8.9.5 3SBio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genetic Engineering Drug Value Chain Analysis
  2. 9.1.1 Genetic Engineering Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genetic Engineering Drug Production Mode & Process
  6. 9.2 Genetic Engineering Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genetic Engineering Drug Distributors
  9. 9.2.3 Genetic Engineering Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst